Causality of Opportunistic Pathogen Klebsiella pneumoniae to Hypertension Development

Abstract

Background: Previous studies have reported a strong association between gut microbiome and hypertension; yet, the exact bacterial species associated with the disease development and progression have not yet been detected. This study aimed to investigate whether opportunistic pathogen Klebsiella pneumoniae is a causal factor for hypertension pathogenesis, and explore the potential mechanisms. Methods: The enrichment of Klebsiella pneumoniae in the gut of patients with hypertension was validated by meta-analysis based on 3 independent cohorts. Klebsiella pneumoniae was inoculated into germ-free mice, antibiotic pretreated and conventional mice. Results: Klebsiella pneumoniae led to higher blood pressure, slight cardiac hypertrophy, and enhanced contractility of resistant arteries in recipient mice. Moreover, Klebsiella pneumoniae induced pathological damages, deficiency of tight junction proteins and transcriptional shifts. Metabolic alterations, especially the depletion of stearoylethanolamide, were observed upon Klebsiella pneumoniae administration. In addition, renal transcriptome dysfunction with significant upregulation of genes related to hypertension pathogenesis was observed in Klebsiella pneumoniae treated mice. Conclusions: These results provide evidence that the enrichment of Klebsiella pneumoniae acts as a direct contributor to blood pressure elevation and hypertension pathogenesis, and Klebsiella pneumoniae induced intestinal damages, fecal metabolic changes, and renal shifts may be integrated mediators.

A cross-sectional study identifying disparities in serum metabolic profiles among hypertensive patients with ISH, IDH and SDH subtypes

“…Whereas 12-hydroxystearic acid showed positive correlation with Klebsiella sp. such as Klebsiella pneumoniae , which has been confirmed to drive high BP and HTN in mice ( 26 ). Supplementary Figures S6E–H described the relationships of gut genera/species and metabolites in ES+ between SDH and controls.…”

Kidney microbiota dysbiosis contributes to the development of hypertension

“…K.pn elicited much higher systolic blood pressure in GF-recipient mice than in untreated controls. 36 We suspect that the renal bacteria may be relevant to pyelonephritis or cystitis with exogenous pathogens deriving from the bladder and urinary tracts of these animals. Relatively uniform globular bacteria with low biomass inside the cytoplasm of the renal interstitial cells were considered endogenous bacteria, whereas exogenous bacteria differed randomly in abundance and morphology and could not reach the cytoplasm.…”

Exploring a novel therapeutic strategy: the interplay between gut microbiota and high-fat diet in the pathogenesis of metabolic disorders

“…Healthy microbiota can reduce inflammation levels and alleviate target organ damage in hypertension by regulating metabolites, such as the production of anti-inflammatory short-chain fatty acids ( 178 ). Li et al ( 179 ) discovered that the enrichment of pathogenic bacteria Klebsiella pneumoniae in the gut caused intestinal damage, fecal metabolome alterations, and bacterial translocation to the kidneys, which may contribute to the development of hypertension and high blood pressure. This provides new insights for exploring prevention and treatment strategies for hypertension.…”